HRS-1893
- Generic Name
- HRS-1893
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06775834
- Locations
- 🇨🇳
Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Phase 2
Recruiting
- Conditions
- Non-obstructive Hypertrophic Cardiomyopathy
- Interventions
- Drug: HRS-1893 placebo
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT06816251
- Locations
- 🇨🇳
Fuwai Hospital, Beijing, Beijing, China
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Phase 2
Active, not recruiting
- Conditions
- Obstructive Hypertrophic Cardiomyopathy
- Interventions
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT06516068
- Locations
- 🇨🇳
Fuwai Hospital Chinese Academy of Medical Sciences (CAMS), Beijing, Beijing, China
A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
Phase 1
Completed
- Conditions
- Obstructive Hypertrophic Cardiomyopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Target Recruit Count
- 76
- Registration Number
- NCT05879523
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath